-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Amgen Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Amgen Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $45 M, a 92.5% decline year-over-year.
- Amgen Inc Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $582 M, a 51.3% decline year-over-year.
- Amgen Inc annual Income Tax Expense (Benefit) for 2023 was $1.14 B, a 43.3% increase from 2022.
- Amgen Inc annual Income Tax Expense (Benefit) for 2022 was $794 M, a 1.73% decline from 2021.
- Amgen Inc annual Income Tax Expense (Benefit) for 2021 was $808 M, a 7.02% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)